Stoke Therapeutics Inc. trailing returns
How Stoke Therapeutics Inc. (STOK) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -1.8% | +0.0% | -1.8% | — |
| 5 days | -2.3% | +0.0% | -2.3% | -9.1%Oct 13 |
| 1 month | -13.4% | +0.0% | -13.4% | -22.9%Oct 13 |
| YTD | -23.8% | +0.0% | -23.8% | -41.3%Oct 13 |
| 1 year | -29.3% | +0.0% | -29.3% | -41.3%Oct 2026 |
| 5 years | +0.5% | +0.0% | +0.5%+2.8% | -89.0%Oct 2023 |
| Since inception (2019) | -0.8% | +0.0% | -0.8%-5.5% | -95.2%Oct 2023 |
Growth of STOK#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+0.5%/year · +2.8%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in STOK's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Stoke Therapeutics Inc.'s return since inception?
- Since 2019, Stoke Therapeutics Inc. (STOK) has compounded at about -0.8% a year — -5.5% in total.